RenovoRx (NASDAQ:RNXT) Stock Price Down 7.6%
RenovoRx (NASDAQ:RNXT) Stock Price Down 7.6%
RenovoRx, Inc. (NASDAQ:RNXT – Get Rating)'s stock price traded down 7.6% during trading on Wednesday . The stock traded as low as $3.54 and last traded at $3.65. 354,715 shares traded hands during trading, an increase of 346% from the average session volume of 79,574 shares. The stock had previously closed at $3.95.
RenovorX, Inc.(纳斯达克股票代码:RNXT — 获取评级)的股价在周三的交易中下跌了7.6%。该股的交易价格低至3.54美元,最后一次交易价格为3.65美元。交易期间有354,715股股票交易,较79,574股的平均交易量增长了346%。该股此前收于3.95美元。
RenovoRx Stock Performance
RenovorX 股票表现
The company has a market cap of $33.11 million, a price-to-earnings ratio of -3.72 and a beta of 0.25. The stock's fifty day moving average is $2.23 and its two-hundred day moving average is $2.13.
该公司的市值为3311万美元,市盈率为-3.72,beta值为0.25。该股的五十天移动平均线为2.23美元,其两百天移动平均线为2.13美元。
RenovoRx (NASDAQ:RNXT – Get Rating) last issued its quarterly earnings data on Monday, November 14th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. On average, equities research analysts expect that RenovoRx, Inc. will post -1.11 EPS for the current year.
RenovorX(纳斯达克股票代码:RNXT — Get Rating)上次发布季度收益数据是在11月14日星期一。该公司公布了本季度每股收益(0.24美元),比市场普遍预期的(0.27美元)高出0.03美元。股票研究分析师平均预计,RenovorX, Inc.今年每股收益将为-1.11美元。
Hedge Funds Weigh In On RenovoRx
对冲基金对 RenovorX 进行了权衡
RenovoRx Company Profile
RenovorX 公司简介
(Get Rating)
(获取评分)
RenovoRx, Inc, a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer.
RenovorX, Inc是一家临床阶段的生物制药公司,专注于开发治疗实体瘤的疗法。其主要候选产品是RenovoGem,这是一种由动脉内吉西他滨和RenovoCath组成的药物和器械组合,目前正在进行局部晚期胰腺癌的III期临床试验。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on RenovoRx (RNXT)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- 免费获取 StockNews.com 关于 RenovorX (RNXT) 的研究报告的副本
- 宝洁公司收益:一场值得一试的赌博
- 股市下滑,经济报告描绘了经济的阴暗前景
- Nu Holdings 的股票与沃伦·巴菲特有什么关系?
- J.B. Hunt 持平,物流公司成为人们关注的焦点
- 英特尔股票即将爆发吗?
Receive News & Ratings for RenovoRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovoRx and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 RenovorX 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收RenovorX及相关公司的最新新闻和分析师评级的简明每日摘要。